Domestic Medical Device Makers Shine as 23-Province Suture Tender Enters Allocation Phase

The billion-dollar market for surgical sutures is welcoming aStructurally LargeShuffle, the pattern of foreign capital monopoly has been torn open.

01

From Foreign Monopoly to Domestic Breakthrough,

Billion-Dollar MarketThe Great Reshuffle

1Month15Day, Sichuan Provincial Drug and Medical Device Bidding and Procurement Service CenterPublish "Regarding the Launch of the Provincial Alliance for Sutures, etc. Led by Liaoning Province5Notice on Determining the Agreement Purchase Volume for Selected Products in the Centralized Bulk Procurement of Medical Consumables》, to carry out the work of determining the procurement volume for the suture alliance's centralized procurement agreement.

The above-mentioned centralized procurement is the largest-scale volume-based procurement that the suture market in China has ever experienced.，Procurement Categories CoverAbsorbable Sutures and Non-Absorbable Sutures Full Range，Participating regions includeTianjin, Hebei,Sichuan,Liaoningetc.23Provinces (Regions, Municipalities) andXinjiang Production and Construction Corps，Industry influence comparable to once"Small Country Procurement"，The resultWillDirectRewrite the suture market landscape.

The schedule for the centralized procurement is very tight.。GoYear12Month31Day，Liaoning Province Public Resources Trading CenterAlreadyRelease of Centralized Procurement Selection Results。According to the latest notice from Sichuan, the filing time for medical institutions is2026Year1Month19Date2Month2Day, and it is expected that other alliance regions will also successively initiate related work.During this period, the suture brands entering the final round of centralized procurement will officially confirm the future market distribution.。

According to data from the China Association for Medical Devices Industry,2023The scale of China's surgical suture market broke through in 202380Hundred Million。QYResearchPrediction,2029The scale of China's suture market willIncrease to18.4Billion USD, Compound Annual Growth Rate (CAGR)8.6%。

ThisOneThe large market has long been dominated by foreign brands, with multinational giants such as Johnson & Johnson and Medtronic occupying a significant share.75%AboveThe market share, especially in high-end fields such as absorbable sutures, has almost formed a monopolistic situation. Chinese suture enterprises started relatively late and have been restricted by factors such as capital, technology, and talent, resulting in their products being concentrated in low value-added categories for a long time.

However,This conditionChanging。

In recent years, suture enterprises in China have continued to innovate and accumulate developmental momentum; the market transformation only awaits a new opportunity.Different from the previous local level“A Small Trial”，This Year, the Suture Market is Facing a MajorAlliance Centralized Procurement，The original price system and competitive landscapeIt was broken, and the domestically produced sutures represented by Jian Shi Hua Kang also ushered in their true moment of glory.

02

Three Wins in Three Centralized Procurement Campaigns, Demonstrating"通关"实力

Why Do Domestically Produced Sutures Keep Winning?

In fact, in previous procurement practices, domestically produced sutures have already begun to show their potential.

2023YearHebei Led the Sanming Alliance in Centralized Procurement, Including Barbed Sutures in the Volume-Based Procurement Scope for the First Time. In this competition, Jian Shi sutures...The First PlaceSelected, Obtained20%Minimum guaranteed purchase volume.2024YearFujian Launches Absorbable Sutures Centralized Procurement. Genius Sutures Products Stand Out Again, with Multiple Products like Knotless Sutures and Antibacterial Sutures.GroupingAll withAGroup First PlaceSelected.Repeated experience in centralized procurement has enabled Jian Shi Hua Er Kang to accumulate valuable policy understanding and market response capabilities. As of now, its suture products have entered the entire country.2000YU FamilyThe hospital is serving a large number of patients.

Technological revolution is an important reliance for Gensight to launch this battle for the turnaround of domestically-produced sutures.

2023Year, Jian Shi Medical's triclosan-coated absorbable surgical sutures have been approved for marketing, becomingThe First Antibacterial Suture Produced in China, breaking the long-term monopoly of imported brands in the antibacterial suture market.2024Year, Jian Shi Medical'sThe First Barbed Suture Made in ChinaSuccessfully approved, filling the gap in barbed sutures produced in China.Another细分领域的Blank.2025Year3Month, Genius achieves another breakthrough,Approval Obtained for Antibacterial Fishbone Barb Thread, becoming the first to攻克 the integration of antibacterial and barb technologyChallengeProducts produced in China have achieved a breakthrough from single-function to multi-functional technological innovation.GenderCrossing.

“Gensite Antibacterial Sutures Are Breaking the Monopoly of Imported Brands in the Antibacterial Sutures Market.”A nurse in a certain hospital's operating room revealed.According to reports,In many hospitals across China, the Walcan brand has been implemented.100%Import substitution.

03

Continuously Accumulating Energy, Building a Full-Industry-Chain Moat

InNormalization of Centralized ProcurementAgainst the broader backdrop, whether medical device companies can withstand the test with strong resilience and seize opportunities to achieve market breakthroughs has become an industry watershed.

Geesun HealthBehind the perfect答卷 is持续的IndustryAccumulation. Currently,Grape Medical has builtStartComplete SuturesInnovationProduct matrix, forming a powerfulEntire Industry ChainMoat.

Absorbable Sutures: Covering general absorbable and antibacterial sutures (*1.39Times), Puncture-resistant (*1.44Times), anti-bacterial puncture-resistant controlled-release multi-needle, long-absorption single-strand (*1.94Times) Multiple needles, etc.

Absorbable knotless sutures: Covered antibacterial, non-antibacterial, cutting barbed sutures, antibacterial fishbone barbed sutures (*1.29Times), etc.

Non-absorbable suture: Leak-proof coating (*1.9Times) Special physicochemical products, etc.

It can be seen that，Gynex Walleon's multi-package of controlled-release needles (also known as easy-off needles)对标imported brands、Antibacterial Fishbone LineWait until trulyMeetClinicalDemandThe subtleties, consideringGetMore comprehensive, able toEffectivelyFormationFor imported brandsThe domestic substitution.

The full product line layout enables Jian Shi Hua Er Kang to meet the needs of different clinical scenarios and gain a significant advantage in centralized procurement.InIn terms of production capacity assurance, Genius Medical continues to increase its investment in research and development and production.2024Year5Month, the second phase of Jian Shi Medical Wuxi R&D and Production Base project officially commenced construction, with a total investment of nearly10100 million yuan, with a construction area of1.7Million square meters. It is expected to create an accumulated total of over60100 Million YuanOutput value. The continuous expansion of modern production lines will effectively ensure the stable supply of large-scale products after centralized procurement.

InGiant HealthcareRepresented byLocalSutureBrand，With the continuous accumulation of technical strength and stable product quality, the market pattern dominated by foreign brands is changing. In the next few years, China's suture market will enter a new round of rapid integration period., owningChinese enterprises with innovative technology, comprehensive product lines, and strong supply capabilities are expected toYuWinning Greater Development Space in the Market Restructuring Brought by Centralized Procurement。